Monopar Therapeutics Inc. (MNPR) market cap

Market cap today
$481.56M

Monopar Therapeutics Inc. (MNPR) has a market cap of $481.56M. At the end of fiscal 2025 (December 31, 2025) its market cap was $483.95M. That is 480.4% higher than the $83.38M of fiscal 2024. Today's figure is 0.5% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 07:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$481.56M
Market cap, fiscal 2025
$483.95M
Change on fiscal 2024
+480.4%
Highest on record
$483.95Mfiscal 2025
Lowest on record
$4.70Mfiscal 2023
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Monopar Therapeutics Inc. market cap, in more detail

Across the 5 fiscal year-ends on record (2021–2025), the highest was $483.95M in fiscal 2025 and the lowest $4.70M in fiscal 2023.

History · 5 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Monopar Therapeutics Inc. market cap, year by year

Monopar Therapeutics Inc. (MNPR) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$481.56M—$71.06—
2025$483.95M 480.4% up$65.307.41M
2024$83.38M 1,674.1% up$22.003.79M
2023$4.70M 84.4% down$1.702.76M
2022$30.14M 24.7% down$11.852.54M
2021$40.03M—$16.052.49M
2020——$30.60—
2019——$83.00—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on MNPR

Monopar Therapeutics Inc., figure by figure

Monopar Therapeutics Inc. (MNPR) overview: price, valuation and scorecard

Monopar Therapeutics Inc. market cap: questions and answers

What is Monopar Therapeutics Inc.'s market cap?

Monopar Therapeutics Inc. (MNPR) has a market cap of $481.56M. At the end of fiscal 2025 (December 31, 2025) its market cap was $483.95M. That is 480.4% higher than the $83.38M of fiscal 2024.

What are the highest and lowest market cap figures on record for Monopar Therapeutics Inc.?

Across the 5 fiscal year-ends on record (2021–2025), the highest was $483.95M in fiscal 2025 and the lowest $4.70M in fiscal 2023.

How is Monopar Therapeutics Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Monopar Therapeutics Inc. (MNPR) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/MNPR/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.